We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Dechra Pharmaceuticals Plc | LSE:DPH | London | Ordinary Share | GB0009633180 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 3,866.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMDPH
RNS Number : 3558N
Dechra Pharmaceuticals PLC
23 September 2019
23 September 2019
Dechra(R) Pharmaceuticals PLC
(Dechra or the Company)
Notification and public disclosure of transactions by
persons discharging managerial responsibilities (PDMRs)
Dechra Pharmaceuticals PLC announces that on 19 September 2019, the following PDMRs exercised nil cost options over ordinary shares of 1p each in the Company. The options were granted to them on 19 September 2016 pursuant to the Dechra Pharmaceuticals PLC Long Term Incentive Plan (the LTIP). The exercise of the options was subject to the achievement of performance conditions which were satisfied in full so that the options vested at 100%. Ian Page sold sufficient shares (acquired pursuant to the exercise) in order to fund the resulting tax liability and Tony Griffin sold all of the shares (acquired pursuant to the exercise).
Hot Features
Premium
Name Capacity Options Shares Sale Price Total beneficial Percentage
Exercised Sold per share shareholding of issued
following this share capital
announcement
Ian Page Director 73,260 34,536 GBP27.893745 625,374 0.608%
Tony Griffin Director 20,858 20,858 GBP27.893745 70,606 0.069%
The Notification of Dealing Forms set out below are provided in accordance with the requirements of the EU Market Abuse Regulation.
Notification of Dealing Form
1. Details of the Person Discharging Managerial Responsibility
("PDMR")/person closely associated with them ("PCA")
a) Name Ian Page
---------------------------------- ---------------------------------------
2. Reason for the notification
---------------------------------------------------------------------------
a) Position/status Director/PDMR
---------------------------------- ---------------------------------------
b) Initial notification/ Initial Notification
amendment
---------------------------------- ---------------------------------------
3. Details of the Issuer
---------------------------------------------------------------------------
a) Name Dechra Pharmaceuticals PLC
---------------------------------- ---------------------------------------
b) LEI code 213800J4UVB5OWG8VX82
---------------------------------- ---------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
where transactions have been conducted
---------------------------------------------------------------------------
a) Description of Ordinary Shares of 1 pence each
the financial
instrument
ISIN: GB0009633180
Identification
code
---------------------------------- ---------------------------------------
b) Nature of the Exercise of 73,260 options under the
transaction Company's Long Term Incentive Plan
---------------------------------- ---------------------------------------
c) Price(s) and volumes(s) Price(s) Volume(s)
GBPNil Cost 73,260
---------------------------------- ---------------------- ---------------
d) Aggregated information
* Aggregate volume
N/A
* Price
---------------------------------- ---------------------------------------
e) Date of the transaction 2019.09.19
---------------------------------- ---------------------------------------
f) Place of the transaction Outside a trading venue
---------------------------------- ---------------------------------------
1. Details of the Person Discharging Managerial Responsibility
("PDMR")/person closely associated with them ("PCA")
a) Name Ian Page
--------------------------------- ------------------------------------------
2. Reason for the notification
-----------------------------------------------------------------------------
a) Position/status Director/PDMR
--------------------------------- ------------------------------------------
b) Initial notification/ Initial Notification
amendment
--------------------------------- ------------------------------------------
3. Details of the Issuer
-----------------------------------------------------------------------------
a) Name Dechra Pharmaceuticals PLC
--------------------------------- ------------------------------------------
b) LEI code 213800J4UVB5OWG8VX82
--------------------------------- ------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
where transactions have been conducted
-----------------------------------------------------------------------------
a) Description of Ordinary Shares of 1 pence each
the financial
instrument
ISIN: GB0009633180
Identification
code
--------------------------------- ------------------------------------------
b) Nature of the Partial sale of shares obtained under
transaction the Company's Long Term Incentive Plan
to satisfy tax liability
--------------------------------- ------------------------------------------
c) Price(s) and volumes(s) Price(s) Volume(s)
GBP27.893745 34,536
--------------------------------- ------------------------ ----------------
d) Aggregated information
* Aggregate volume 34,536
GBP27.893745
* Price GBP963,338.38
* Total
--------------------------------- ------------------------------------------
e) Date of the transaction 2019.09.20
--------------------------------- ------------------------------------------
f) Place of the transaction London Stock Exchange
--------------------------------- ------------------------------------------
1. Details of the Person Discharging Managerial Responsibility
("PDMR")/person closely associated with them ("PCA")
a) Name Tony Griffin
------------------------------------- ---------------------------------------
2. Reason for the notification
------------------------------------------------------------------------------
a) Position/status Director/PDMR
------------------------------------- ---------------------------------------
b) Initial notification/ Initial Notification
amendment
------------------------------------- ---------------------------------------
3. Details of the Issuer
------------------------------------------------------------------------------
a) Name Dechra Pharmaceuticals PLC
------------------------------------- ---------------------------------------
b) LEI code 213800J4UVB5OWG8VX82
------------------------------------- ---------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
where transactions have been conducted
------------------------------------------------------------------------------
a) Description of Ordinary Shares of 1 pence each
the financial
instrument
ISIN: GB0009633180
Identification
code
------------------------------------- ---------------------------------------
b) Nature of the Exercise of 20,858 options under the
transaction Company's Long Term Incentive Plan
------------------------------------- ---------------------------------------
c) Price(s) and volumes(s) Price(s) Volume(s)
GBPnil 20,858
------------------------------------- ------------------ -------------------
d) Aggregated information
* Aggregate volume
N/A
* Price
------------------------------------- ---------------------------------------
e) Date of the transaction 2019.09.19
------------------------------------- ---------------------------------------
f) Place of the transaction Outside a trading venue
------------------------------------- ---------------------------------------
1. Details of the Person Discharging Managerial Responsibility
("PDMR")/person closely associated with them ("PCA")
a) Name Tony Griffin
--------------------------------- ----------------------------------------------
2. Reason for the notification
---------------------------------------------------------------------------------
a) Position/status Director/PDMR
--------------------------------- ----------------------------------------------
b) Initial notification/ Initial Notification
amendment
--------------------------------- ----------------------------------------------
3. Details of the Issuer
---------------------------------------------------------------------------------
a) Name Dechra Pharmaceuticals PLC
--------------------------------- ----------------------------------------------
b) LEI code 213800J4UVB5OWG8VX82
--------------------------------- ----------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
where transactions have been conducted
---------------------------------------------------------------------------------
a) Description of Ordinary Shares of 1 pence each
the financial
instrument
ISIN: GB0009633180
Identification
code
--------------------------------- ----------------------------------------------
b) Nature of the Sale of shares obtained under the Company's
transaction Long Term Incentive Plan.
--------------------------------- ----------------------------------------------
c) Price(s) and volumes(s) Price(s) Volume(s)
GBP27.893745 20,858
--------------------------------- --------------------------- -----------------
d) Aggregated information
* Aggregate volume 20,858
GBP27.893745
* Price GBP581,807.73
* Total
--------------------------------- ----------------------------------------------
e) Date of the transaction 2019.09.20
--------------------------------- ----------------------------------------------
f) Place of the transaction London Stock Exchange
--------------------------------- ----------------------------------------------
For further information, please contact:
Melanie Hall, Company Secretary
Telephone number: 01606 814730
About Dechra
Dechra is a global specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. For more information please visit: www.dechra.com
Trademarks
Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
DSHCKNDQPBKDOCB
(END) Dow Jones Newswires
September 23, 2019 11:50 ET (15:50 GMT)
1 Year Dechra Pharmaceuticals Chart |
1 Month Dechra Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
